Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine plus azithromycin versus placebo for outpatient COVID-19
RBR-95yjmqPhase 3Completed
- Sponsor
- Hospital Santa Paula
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine plus azithromycin with Placebo (2 arms). Primary endpoint: SARS-CoV-2 viral load negativization. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-95yjmq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-95yjmq.